Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

11.14
Delayed Data
As of 3:59pm ET
 +0.54 / +5.09%
Today’s Change
5.09
Today|||52-Week Range
11.69
+98.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues9.3M7.3M8.3M10.2M
 
 
 
 
 
Cost of Goods Sold4.6M4.4M4.4M5.1M
 
 
 
 
 
Depreciation And Amortization515.0K--523.0K507.0K
 
 
 
 
 
Operating ExpensesGross Income4.2M2.8M3.4M4.6M
 
 
 
 
 
General Expenses2.6M2.6M4.3M5.0M
 
 
 
 
 
Research And Development236.0K351.0K1.4M2.1M
 
 
 
 
 
Total Operating Expenses7.7M7.0M9.2M10.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.6M260.0K-831.0K-333.0K
 
 
 
 
 
Extraordinary Credit1.0K--0.000.00
 
 
Extraordinary Charge-300.0K--0.000.00
 
 
Interest Expense On Debt29.0K26.0K27.0K27.0K
 
 
 
 
 
Other Expenses2.3M192.0K171.0K37.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.6M426.0K-687.0K-323.0K
 
 
 
 
 
Income Taxes-110.0K-920.0K-5.0K-3.0K
 
 
 
 
 
Preferred Dividend-7.0K0.000.00-7.0K
 
 
 
Net Income3.7M-494.0K-692.0K-326.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.7M10.8M10.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted10.8M10.8M10.8M10.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.34-$0.05-$0.06-$0.03
 
 
 
 
 
EPS Diluted$0.34-$0.05-$0.06-$0.03